ArticleThe Journal of urology2012
Re: immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas.
Samir S TanejaPubMed ↗Publisher ↗
No numbers read from the abstract.